New Research on Omega-3 Fatty Acid DPA to be Presented at Experimental Biology 2014
Houston, TX, April 21, 2014 — New research on omega-3 fatty acid Docosapentaenoic acid, DPA, will be presented at Experimental Biology 2014. This meeting will be held on April 26-30, 2014 at the San Diego Convention Center. Results of two separate studies will be presented by study co-author Amanda Pepper-Yowell, doctoral candidate at Texas Tech University, Department of Animal and Food Science. Both studies were sponsored by Omega Protein Corporation and conducted by Texas Tech University.
Results from the first study showed that purified EPA, DPA, DHA, and menhaden-oil-derived OmegaActiv® Super DPA improved serum lipid profiles in mice. It also demonstrates that DPA decreases aortic plaque building, revealing its potential to help reduce atherosclerosis. The study will be featured as part of a mini-symposium entitled “Medical Nutrition: Nutrition and Inflammation” on Saturday, April 26 at 10:30 a.m., Room 29C.
Findings from the second study on anti-inflammatory effects of DPA in cell culture model will be highlighted during poster session 1034.16 on Tuesday, April 29 between 1:45 – 2:45 p.m. in the exhibit halls. This study showed molecular mechanisms of anti-inflammatory action of DPA, which is especially revealing since many chronic diseases including heart disease, atherosclerosis and obesity have an inflammatory component.
“Science focused specifically on DPA is on the rise and the scientific community is increasingly recognizing DPA’s therapeutic potential to work with EPA and DHA, and as a stand-alone fatty acid,” stated Dr. Mark E. Griffin, Senior Vice President of Research and Development at Omega Protein Corporation. “These two studies reveal DPA’s important role in health and both will be published in peer-reviewed journals in the immediate future.”
DPA is an exciting ‘new’ omega-3 fatty acid. DPA has always been around, but research is increasingly recognizing its significance on human health. DPA is structurally similar to EPA with two more carbon chain units. The body can store twice the amount of DPA in blood as EPA and about half as much DPA as DHA. Omega Protein Corporation, through its human nutrition division Nutegrity™, supplies menhaden fish oil that contains significantly higher levels of DPA compared to typical fish oil sources like sardines and anchovies. The company’s fish oils, OmegaActiv® (dietary supplement applications) and OmegaPure® (food and beverage applications), are produced through a vertically integrated supply chain allowing for control of every step of the production process ensuring product integrity, consistent quality and complete traceability.
ABOUT OMEGA PROTEIN
Omega Protein Corporation (NYSE: OME) is a century old nutritional company that develops, produces, and delivers healthy products throughout the world to improve the nutritional integrity of functional foods, dietary supplements, and animal feeds. Omega Protein’s mission is to help people lead healthier lives with better nutrition through sustainably sourced ingredients such as highly-refined, omega-3 rich fish oil, specialty proteins, and nutraceuticals.
ABOUT EXPERIMENTAL BIOLOGY 2014
Experimental Biology is an annual meeting comprised of over 14,000 scientists and exhibitors representing six sponsoring societies and multiple guest societies. This multidisciplinary, scientific meeting features plenary and award lectures, pre-meeting workshops, oral and posters sessions, on-site career services and exhibits of an array of equipment, supplies and publications required for research labs and experimental study. General fields of study include anatomy, physiology, pathology, biochemistry, nutrition, and pharmacology. For more information visit https://experimentalbiology.org/2014/Home.aspx.